Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dorry Segev and Allan Massie.
Dorry Segev
Connection Strength
10.139
Allan Massie
  1. Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study. Am J Transplant. 2020 11; 20(11):2997-3007.
    View in: PubMed
    Score: 0.892
  2. Quantifying Postdonation Risk of ESRD in Living Kidney Donors. J Am Soc Nephrol. 2017 Sep; 28(9):2749-2755.
    View in: PubMed
    Score: 0.714
  3. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856.
    View in: PubMed
    Score: 0.242
  4. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332.
    View in: PubMed
    Score: 0.238
  5. Response to "COVID-19 in SOT versus non-SOT". Am J Transplant. 2021 06; 21(6):2306.
    View in: PubMed
    Score: 0.233
  6. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021 07; 21(7):2498-2508.
    View in: PubMed
    Score: 0.233
  7. Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic. Transplantation. 2021 01 01; 105(1):170-176.
    View in: PubMed
    Score: 0.230
  8. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant. 2021 05; 21(5):1838-1847.
    View in: PubMed
    Score: 0.228
  9. Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community. Am J Transplant. 2020 11; 20(11):3123-3130.
    View in: PubMed
    Score: 0.226
  10. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020 11; 20(11):3131-3139.
    View in: PubMed
    Score: 0.224
  11. Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System. Transplantation. 2020 07; 104(7):1456-1461.
    View in: PubMed
    Score: 0.223
  12. Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors. Clin J Am Soc Nephrol. 2019 10 07; 14(10):1493-1499.
    View in: PubMed
    Score: 0.211
  13. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study. Transplantation. 2019 06; 103(6):1216-1223.
    View in: PubMed
    Score: 0.206
  14. Anxiety, depression, and regret of donation in living kidney donors. BMC Nephrol. 2018 09 04; 19(1):218.
    View in: PubMed
    Score: 0.196
  15. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study. Transplantation. 2018 09; 102(9):1514-1519.
    View in: PubMed
    Score: 0.196
  16. MELD allocation system: There is always space to improve. Am J Transplant. 2018 11; 18(11):2834-2835.
    View in: PubMed
    Score: 0.195
  17. Consent and labeling in the use of infectious risk donor kidneys: A response to "Information Overload". Am J Transplant. 2018 10; 18(10):2608-2609.
    View in: PubMed
    Score: 0.194
  18. Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study. Transplantation. 2018 07; 102(7):1148-1155.
    View in: PubMed
    Score: 0.194
  19. Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata. Nephrol Dial Transplant. 2018 07 01; 33(7):1251-1259.
    View in: PubMed
    Score: 0.194
  20. Interviews of living kidney donors to assess donation-related concerns and information-gathering practices. BMC Nephrol. 2018 06 08; 19(1):130.
    View in: PubMed
    Score: 0.193
  21. Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation. 2018 03; 102(3):471-477.
    View in: PubMed
    Score: 0.189
  22. Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr. 2018 03; 66(3):436-441.
    View in: PubMed
    Score: 0.189
  23. MELD as a metric for survival benefit of liver transplantation. Am J Transplant. 2018 05; 18(5):1231-1237.
    View in: PubMed
    Score: 0.189
  24. Electronic messaging and communication with living kidney donors. Clin Transplant. 2018 02; 32(2).
    View in: PubMed
    Score: 0.188
  25. Fifteen-Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts. J Pediatr. 2018 05; 196:148-153.e2.
    View in: PubMed
    Score: 0.187
  26. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014. JAMA. 2018 01 02; 319(1):49-61.
    View in: PubMed
    Score: 0.187
  27. Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys. Am J Transplant. 2018 03; 18(3):617-624.
    View in: PubMed
    Score: 0.186
  28. Factors associated with perceived donation-related financial burden among living kidney donors. Am J Transplant. 2018 03; 18(3):715-719.
    View in: PubMed
    Score: 0.186
  29. Persistent regional and racial disparities in nondirected living kidney donation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.185
  30. Patterns of primary care utilization before and after living kidney donation. Clin Transplant. 2017 07; 31(7).
    View in: PubMed
    Score: 0.180
  31. The Authors Reply. Kidney Int. 2017 05; 91(5):1256.
    View in: PubMed
    Score: 0.179
  32. Concerns about the long-term safety of live kidney donors are justified. Eur J Epidemiol. 2017 02; 32(2):91-93.
    View in: PubMed
    Score: 0.177
  33. The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery. Ann Plast Surg. 2017 Mar; 78(3):315-323.
    View in: PubMed
    Score: 0.177
  34. Access to Kidney Transplantation among HIV-Infected Waitlist Candidates. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):467-475.
    View in: PubMed
    Score: 0.176
  35. Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int. 2017 03; 91(3):699-703.
    View in: PubMed
    Score: 0.175
  36. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients. Clin Infect Dis. 2022 01 07; 74(1):83-91.
    View in: PubMed
    Score: 0.062
  37. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281.
    View in: PubMed
    Score: 0.061
  38. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271.
    View in: PubMed
    Score: 0.061
  39. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
    View in: PubMed
    Score: 0.061
  40. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174.
    View in: PubMed
    Score: 0.061
  41. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123.
    View in: PubMed
    Score: 0.060
  42. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366.
    View in: PubMed
    Score: 0.060
  43. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588.
    View in: PubMed
    Score: 0.060
  44. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83.
    View in: PubMed
    Score: 0.060
  45. Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs. Clin Transplant. 2021 08; 35(8):e14376.
    View in: PubMed
    Score: 0.059
  46. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713.
    View in: PubMed
    Score: 0.059
  47. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 06 01; 325(21):2204-2206.
    View in: PubMed
    Score: 0.059
  48. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 05 04; 325(17):1784-1786.
    View in: PubMed
    Score: 0.059
  49. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57.
    View in: PubMed
    Score: 0.059
  50. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53.
    View in: PubMed
    Score: 0.059
  51. Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 2021 01 01; 105(1):216-224.
    View in: PubMed
    Score: 0.058
  52. Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Clin Transplant. 2020 12; 34(12):e14086.
    View in: PubMed
    Score: 0.057
  53. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol. 2021 01; 36(1):143-151.
    View in: PubMed
    Score: 0.057
  54. Early Experiences With COVID-19 Testing in Transplantation. Transplant Direct. 2020 Jul; 6(7):e572.
    View in: PubMed
    Score: 0.055
  55. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020 07; 20(7):1809-1818.
    View in: PubMed
    Score: 0.055
  56. National Variation in Increased Infectious Risk Kidney Offer Acceptance. Transplantation. 2019 10; 103(10):2157-2163.
    View in: PubMed
    Score: 0.053
  57. Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation. Transplant Direct. 2019 Aug; 5(8):e474.
    View in: PubMed
    Score: 0.052
  58. Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers. Clin Transplant. 2019 08; 33(8):e13637.
    View in: PubMed
    Score: 0.052
  59. Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. Transplantation. 2019 06; 103(6):1267-1271.
    View in: PubMed
    Score: 0.052
  60. Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System. Am J Transplant. 2019 11; 19(11):3079-3086.
    View in: PubMed
    Score: 0.052
  61. The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 15; 8(1):e11000.
    View in: PubMed
    Score: 0.050
  62. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy. Transplantation. 2018 12; 102(12):2088-2095.
    View in: PubMed
    Score: 0.050
  63. Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study. JMIR Mhealth Uhealth. 2018 Oct 09; 6(10):e11192.
    View in: PubMed
    Score: 0.049
  64. Willingness to Donate Organs Among People Living With HIV. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):e30-e36.
    View in: PubMed
    Score: 0.049
  65. Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers. Clin Transplant. 2018 10; 32(10):e13365.
    View in: PubMed
    Score: 0.049
  66. Correlation Between Kidney Transplant Outcome Metrics and Waitlist Metrics. Transplantation. 2018 08; 102(8):e362-e363.
    View in: PubMed
    Score: 0.049
  67. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors. Ann Surg. 2018 06; 267(6):1161-1168.
    View in: PubMed
    Score: 0.048
  68. Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States. Transplantation. 2018 04; 102(4):609-615.
    View in: PubMed
    Score: 0.048
  69. Decreasing deceased donor transplant rates among children (=6 years) under the new kidney allocation system. Am J Transplant. 2018 07; 18(7):1690-1698.
    View in: PubMed
    Score: 0.047
  70. Deceased-Donor Liver Size and the Sex-Based Disparity in Liver Transplantation. Transplantation. 2017 11; 101(11):e329.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.